Neoadjuvant immunotherapy is reshaping cancer management across multiple tumour types: The future is now!-Reference-Cited by-同舟云学术

Neoadjuvant immunotherapy is reshaping cancer management across multiple tumour types: The future is now!

Published:2021-07 Issue: Volume:152 Page:155-164
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Maio Michele^ORCID,Blank Christian,Necchi Andrea^ORCID,Di Giacomo Anna Maria,Ibrahim Ramy,Lahn Michael^ORCID,Fox Bernard A.^ORCID,Bell R. Bryan^ORCID,Tortora Giampaolo^ORCID,Eggermont Alexander M.M.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference97 articles.

1. Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, Italy;Maio;Cancer Immunol Immunother,2019

2. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis;Cortazar;Lancet,2014

3. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes;von Minckwitz;J Clin Oncol,2012

4. Association of pathologic complete response with long-term survival outcomes in triple-negative breast cancer: a meta-analysis;Huang;Canc Res,2020

5. Pathological complete response and accelerated drug approval in early breast cancer;Prowell;N Engl J Med,2012

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant toripalimab combined with axitinib in patients with locally advanced clear cell renal cell carcinoma: a single-arm, phase II trial;Journal for ImmunoTherapy of Cancer;2024-06

2. The immune landscape and prognostic analysis of CXCL8 immune‐related genes in cervical squamous cell carcinoma;Environmental Toxicology;2024-04-10

3. The future of targeting cytotoxic T-lymphocyte-associated protein-4: Is there a role?;European Journal of Cancer;2024-02

4. Targeting T regulatory (T_reg) cells in immunotherapy-resistant cancers;Cancer Drug Resistance;2024-01-12

5. Immunosurveillance in clinical cancer management;CA: A Cancer Journal for Clinicians;2023-10-25